메뉴 건너뛰기




Volumn 183, Issue 1, 2010, Pages 56-61

Should Patients With Primary Upper Urinary Tract Cancer Receive Prophylactic Intravesical Chemotherapy After Nephroureterectomy?

Author keywords

administration; intravesical; neoplasm recurrence; urinary bladder; urinary tract; urothelium

Indexed keywords

EPIRUBICIN; MITOMYCIN C;

EID: 71249102523     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.08.154     Document Type: Article
Times cited : (52)

References (25)
  • 2
    • 33846329798 scopus 로고    scopus 로고
    • Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection
    • Roupret M., Traxer O., Tligui M., et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol 51 (2007) 709
    • (2007) Eur Urol , vol.51 , pp. 709
    • Roupret, M.1    Traxer, O.2    Tligui, M.3
  • 3
    • 0031397093 scopus 로고    scopus 로고
    • Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumors
    • Racioppi M., D'Addessi A., Alcini A., et al. Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumors. Br J Urol 80 (1997) 707
    • (1997) Br J Urol , vol.80 , pp. 707
    • Racioppi, M.1    D'Addessi, A.2    Alcini, A.3
  • 4
    • 0023789651 scopus 로고    scopus 로고
    • Time-related recurrence rates in patients with upper tract transitional cell carcinoma
    • Hatch T.R., Hefty T.R., and Barry J.M. Time-related recurrence rates in patients with upper tract transitional cell carcinoma. Urology 140 (1998) 40
    • (1998) Urology , vol.140 , pp. 40
    • Hatch, T.R.1    Hefty, T.R.2    Barry, J.M.3
  • 5
    • 27444442638 scopus 로고    scopus 로고
    • Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology
    • Raman J.D., Ng C.K., Boorjian S.A., et al. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. Br J Urol 96 (2005) 1031
    • (2005) Br J Urol , vol.96 , pp. 1031
    • Raman, J.D.1    Ng, C.K.2    Boorjian, S.A.3
  • 6
    • 34247359169 scopus 로고    scopus 로고
    • Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma
    • Muntener M., Nielsen M.E., Romero F.R., et al. Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma. Eur Urol 51 (2007) 1639
    • (2007) Eur Urol , vol.51 , pp. 1639
    • Muntener, M.1    Nielsen, M.E.2    Romero, F.R.3
  • 7
    • 0025600340 scopus 로고
    • Prophylactic intravesical BCG for bladder tumor after surgery of upper tract urothelial carcinomas
    • Kudoh T., Motomura F., Sitoh F., et al. Prophylactic intravesical BCG for bladder tumor after surgery of upper tract urothelial carcinomas. Jpn J Urol 81 (1990) 1857
    • (1990) Jpn J Urol , vol.81 , pp. 1857
    • Kudoh, T.1    Motomura, F.2    Sitoh, F.3
  • 8
    • 0035569273 scopus 로고    scopus 로고
    • Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper tract tumors: a prospective randomized study
    • Sakamoto N., Naito S., Kumazawa J., et al. Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper tract tumors: a prospective randomized study. Int J Urol 8 (2001) 212
    • (2001) Int J Urol , vol.8 , pp. 212
    • Sakamoto, N.1    Naito, S.2    Kumazawa, J.3
  • 9
    • 33847039237 scopus 로고    scopus 로고
    • Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional sell carcinoma
    • Raman J.D., Sosa R.E., Vaughan E.D., et al. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional sell carcinoma. Urology 69 (2007) 251
    • (2007) Urology , vol.69 , pp. 251
    • Raman, J.D.1    Sosa, R.E.2    Vaughan, E.D.3
  • 10
    • 13844266069 scopus 로고    scopus 로고
    • Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract
    • Matsui Y., Utsunomiya N., Ichioka K., et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 65 (2005) 279
    • (2005) Urology , vol.65 , pp. 279
    • Matsui, Y.1    Utsunomiya, N.2    Ichioka, K.3
  • 11
    • 0141923859 scopus 로고    scopus 로고
    • The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract
    • Kang C.H., Yu T.J., Hsieh H.H., et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98 (2003) 1620
    • (2003) Cancer , vol.98 , pp. 1620
    • Kang, C.H.1    Yu, T.J.2    Hsieh, H.H.3
  • 12
    • 33745456655 scopus 로고    scopus 로고
    • The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma
    • Wu C.F., Chang P.L., Chen C.S., et al. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol 176 (2006) 477
    • (2006) J Urol , vol.176 , pp. 477
    • Wu, C.F.1    Chang, P.L.2    Chen, C.S.3
  • 13
    • 55649120887 scopus 로고    scopus 로고
    • Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients
    • Li C.C., Chang T.H., Wu W.J., et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 54 (2008) 1134
    • (2008) Eur Urol , vol.54 , pp. 1134
    • Li, C.C.1    Chang, T.H.2    Wu, W.J.3
  • 14
    • 2442581163 scopus 로고    scopus 로고
    • A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials
    • Sylvester R.J., Oosterlinck W., and van der Meijden A.P. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171 (2004) 2186
    • (2004) J Urol , vol.171 , pp. 2186
    • Sylvester, R.J.1    Oosterlinck, W.2    van der Meijden, A.P.3
  • 15
    • 0026602097 scopus 로고
    • Intravesical instillations of 4-epi-doxorubicin (Epirubicin) in the prophylactic treatment of superficial bladder cancer: results of a controlled prospective study
    • Melekos M.D., Dauaher H., Fokaefs E., et al. Intravesical instillations of 4-epi-doxorubicin (Epirubicin) in the prophylactic treatment of superficial bladder cancer: results of a controlled prospective study. J Urol 147 (1992) 371
    • (1992) J Urol , vol.147 , pp. 371
    • Melekos, M.D.1    Dauaher, H.2    Fokaefs, E.3
  • 16
    • 9044253710 scopus 로고    scopus 로고
    • The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of followup. Medical Research Council Superficial Bladder Cancer Working Party
    • Tolley D.A., Parmar M.K.B., Grigor K.M., et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of followup. Medical Research Council Superficial Bladder Cancer Working Party. J Urol 155 (1996) 1233
    • (1996) J Urol , vol.155 , pp. 1233
    • Tolley, D.A.1    Parmar, M.K.B.2    Grigor, K.M.3
  • 17
    • 0031395353 scopus 로고    scopus 로고
    • Single-dose versus multiple instillation of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pTa transitional-cell bladder tumours: a prospective, randomized controlled study
    • Ali-El-Dein A., Nabeeh A., El-Baz M., et al. Single-dose versus multiple instillation of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pTa transitional-cell bladder tumours: a prospective, randomized controlled study. Br J Urol 79 (1997) 731
    • (1997) Br J Urol , vol.79 , pp. 731
    • Ali-El-Dein, A.1    Nabeeh, A.2    El-Baz, M.3
  • 18
    • 0036716737 scopus 로고    scopus 로고
    • Perioperative single dose instillation of epirubicin or interferon-alfa after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study-Finnbladder III long-term results. The Finnbladder Group
    • Rajala P., Kaasinen E., Raitanen M., et al. Perioperative single dose instillation of epirubicin or interferon-alfa after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study-Finnbladder III long-term results. The Finnbladder Group. J Urol 168 (2002) 981
    • (2002) J Urol , vol.168 , pp. 981
    • Rajala, P.1    Kaasinen, E.2    Raitanen, M.3
  • 19
    • 0025335684 scopus 로고
    • Comparison of different schedules of cyto-static intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients
    • Huland H., Kloppel G., Feddersen I., et al. Comparison of different schedules of cyto-static intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients. J Urol 144 (1990) 68
    • (1990) J Urol , vol.144 , pp. 68
    • Huland, H.1    Kloppel, G.2    Feddersen, I.3
  • 20
    • 0023102588 scopus 로고
    • A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guerin therapy of superficial bladder cancer
    • Badalament R.A., Herr H.W., Wong G.Y., et al. A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guerin therapy of superficial bladder cancer. J Clin Oncol 5 (1987) 441
    • (1987) J Clin Oncol , vol.5 , pp. 441
    • Badalament, R.A.1    Herr, H.W.2    Wong, G.Y.3
  • 21
    • 0033559222 scopus 로고    scopus 로고
    • Unusual clinical presentation of upper urothelial carcinoma in Taiwan
    • Chou Y.H., and Huang C.H. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer 85 (1999) 1342
    • (1999) Cancer , vol.85 , pp. 1342
    • Chou, Y.H.1    Huang, C.H.2
  • 22
    • 0036252310 scopus 로고    scopus 로고
    • Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan
    • Yang M.H., Chen K.K., Yen C.C., et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 59 (2002) 681
    • (2002) Urology , vol.59 , pp. 681
    • Yang, M.H.1    Chen, K.K.2    Yen, C.C.3
  • 23
    • 13844276100 scopus 로고    scopus 로고
    • Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan
    • Yang C.Y., Chiu H.F., Chang C.C., et al. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan. Environ Res 98 (2005) 127
    • (2005) Environ Res , vol.98 , pp. 127
    • Yang, C.Y.1    Chiu, H.F.2    Chang, C.C.3
  • 24
    • 0033011129 scopus 로고    scopus 로고
    • Urothelial lesions in Chinese-herb nephropathy
    • Cosyns J.P., Jadoul M., Squifflet J.P., et al. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 33 (1999) 1101
    • (1999) Am J Kidney Dis , vol.33 , pp. 1101
    • Cosyns, J.P.1    Jadoul, M.2    Squifflet, J.P.3
  • 25
    • 0034622082 scopus 로고    scopus 로고
    • Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)
    • Nortier J.L., Martinez M.C., Schmeiser H.H., et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342 (2000) 1686
    • (2000) N Engl J Med , vol.342 , pp. 1686
    • Nortier, J.L.1    Martinez, M.C.2    Schmeiser, H.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.